MEDNAX (NYSE:MD) reported Q4 2017 earnings this Morning, coming in at $0.87 per share, beating Wall Street’s estimates of $0.83 per Share. Revenue for the quarter came in at $910.82 million beating analyst estimates of $884.55 million Recent Insider Trading for MEDNAX (NYSE:MD)
- On 12/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $51.58 per share and the total transaction amounting to $154,740.00.
- On 11/3/2017 Cesar L Alvarez, Director, sold 10,668 with an average share price of $42.59 per share and the total transaction amounting to $454,350.12.
- On 9/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $42.85 per share and the total transaction amounting to $128,550.00.
- On 6/14/2017 Md Pascal J Goldschmidt, Director, sold 1,969 with an average share price of $57.57 per share and the total transaction amounting to $113,355.33.
- On 6/1/2017 Joseph M Calabro, Insider, sold 23,327 with an average share price of $55.00 per share and the total transaction amounting to $1,282,985.00.
- On 5/5/2017 Manuel Kadre, Director, bought 21,704 with an average share price of $55.79 per share and the total transaction amounting to $1,210,866.16.
Recent Trading for MEDNAX (NYSE:MD) Shares of MEDNAX closed the previous trading session at 50.59 +0.00 0.00% with 50.650001525878906 shares trading hands.